Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest $50 bln stateside implies that sector-specific levies are inevitable. The ...

ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The Global Bipolar Disorder Market report forecasts significant growth from 2025 to 2035, driven by rising prevalence, awareness, and pharmacotherapy ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Ahead of posting its second-quarter results, Netflix (NFLX) closed at $1,274.17. In post-market trade, markets did not react to the strong results and increase in the company’s fiscal year revenue ...

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation ( ...

US stocks put in solid gains on Thursday, with the S&P 500 and Nasdaq both settling at new record highs, following a raft of ...

Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...